E-ISSN: 2619-9467

Contents    Publication Date: 25 Oct 2024
Year 2024 - Volume 34 - Issue 3

Open Access

Peer Reviewed

CASE REPORTS
28 Viewed54 Downloaded

Recurrence and Malignant Transformation Risk After Fertility Sparing Surgery of Recurrent Ovarian Mucinous Cystadenoma on Young Women: Case Report and Systematic Review

Full Text PDF  
JCOG. 2024;34(3):106-10
DOI: 10.5336/jcog.2024-103700
Article Language: EN
Copyright Ⓒ 2024 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ABSTRACT
Mucinous ovarian cystadenoma is a common epithelial benign tumor in young women. However, recurrence and malignant transformation of mucinous ovarian cystadenoma are rarely reported. We report a 32-years old nulliparous woman who was diagnosed with mucinous ovarian cystadenoma, initially presenting with distended stomach and pelvic pain. After initial left partial oophorocystectomy, the patient had recurrence of abdominal mass, of which left salpingo-oophorocystectomy was performed. Several months after previous surgery, the abdominal mass recurred, which from imaging and pathological examination was diagnosed as borderline mucinous ovarian cystadenoma FIGO class IIIB. A systematic review of 19 articles showed risk of total recurrence and malignant transformation on mucinous ovarian cystadenoma were 13.9% and 1.8%, respectively. Furthermore, choosing fertility sparing surgery could increase the risk of recurrence of borderline ovarian cystadenoma.
REFERENCES:
  1. Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol. 2005;24(1):4-25. [PubMed] 
  2. Loizzi V, Selvaggi L, Leone L, Latorre D, Scardigno D, Magazzino F, et al. Borderline epithelial tumors of the ovary: Experience of 55 patients. Oncol Lett. 2015;9(2):912-4. [Crossref]  [PubMed]  [PMC] 
  3. Vasconcelos I, de Sousa Mendes M. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk. Eur J Cancer. 2015;51(5):620-31. [Crossref]  [PubMed] 
  4. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol. 2001;19(10):2658-64. [Crossref]  [PubMed] 
  5. Camatte S, Rouzier R, Boccara-Dekeyser J, Pautier P, Pomel C, Lhomme C, et al. Pronostic et fertilite' apre's traitement conservateur d'une tumeur ovarienne a' la limite de la malignite': revue d'une se'rie continue de 68 cas [Prognosis and fertility results after conservative management of ovarian borderline tumors: review of 68 cases]. Gynecol Obstet Fertil. 2002;30:583-91. [Crossref] 
  6. Wong HF, Low JJ, Chua Y, Busmanis I, Tay EH, Ho TH. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004. Int J Gynecol Cancer. 2007;17(2):342-9. [Crossref]  [PubMed] 
  7. Sugarbaker PH, Dainty LA. Recurrent mucinous ovarian neoplasms: rationale and results of a new treatment plan in four patients. J Case Rep Stud. 2019;7(2):208. [Crossref] 
  8. Niu L, Tian H, Xu Y, Cao J, Zhang X, Zhang J, et al. Recurrence characteristics and clinicopathological results of borderline ovarian tumors. BMC Womens Health. 2021;21(1):134. [Crossref]  [PubMed]  [PMC] 
  9. Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of ovarian serous borderline tumors. Cancer. 1999;85(4):905-11. [Crossref]  [PubMed] 
  10. Gaballa K, Abdelkhalek M, Fathi A, Refky B, Belal K, Elaraby M, et al. Management of borderline ovarian tumors: a tertiary referral center experience in Egypt. Front Surg. 2022;9:962820. [Crossref]  [PubMed]  [PMC]